The Latest Breaking News from FDA

COVID-19 vaccines for kids under 5 may be available in the U.S. as early as March, but there are several hurdles still to clear

Cannabis producer Flora Growth Corp. (NASDAQ: FLGC) announced today that its seeking approval from INVIMA, the Colombian FDA, to begin research on their patent-pending, cannabinoid-based product, citing recent studies stating the possibility of cannabinoids to display viral inhibition.

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have 

FDA decision could come within weeks but big obstacles remain to getting all children inoculated

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to…

Pfizer Inc. and partner BioNTech SE have begun submitting data to U.S. regulators for authorization of their COVID-19 vaccine in children 6 months to 4 years old, according to people familiar with the matter, hastening an effort to get shots to younger kids after the omicron wave caused pediatric infections…

The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension

Vaccine may be available to youngsters below the age of five from February, if FDA approval is granted

After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.

NASDAQ:VIRI

Pfizer is expected to submit a request to the FDA as soon as tomorrow for emergency-use authorization.